LifeWatch AG

DGAP-Adhoc: LifeWatch AG: Agreement signed to utilize Vital Connect Inc.'s HealthPatch(R) MD in its cardiac monitoring business

LifeWatch AG  / Key word(s): Alliance

07.11.2014 21:15

Release of an ad hoc announcement pursuant to Art. 53 KR
---------------------------------------------------------------------------

LifeWatch AG signs agreement to utilize Vital Connect Inc.'s HealthPatch(R)
MD in its cardiac monitoring business

Neuhausen am Rheinfall/Switzerland, November 7, 2014 - LifeWatch AG (SIX
Swiss Exchange: LIFE), a leading provider of medical solutions in remote
cardiac monitoring, is pleased to announce the signing of an agreement with
Vital Connect Inc. to utilize their HealthPatch MD as a 1-lead ECG device
in its cardiac monitoring business.

LifeWatch and Vital Connect are working together to integrate the
HealthPatch MD into LifeWatch's analytical mobile application and reporting
systems with a view to bringing an integrated solution to market in the
first half of 2015.

This move follows on the heels of the development of LifeWatch's already
announced Vital Signs Patch (VSP) which is also due for release in the
first half of 2015. Dr. Stephan Rietiker, CEO of LifeWatch, noted: "I am
very excited about the new partnership as it comprises a breakthrough
technology that will enable LifeWatch to expand its cardiac monitoring
device offerings for patients to include the important patch technology
area." Patch technology is easy to use and should increase the
effectiveness of cardiac monitoring due to higher patient compliance.

Vital Connect Inc.'s HealthPatch MD biosensor for monitoring patients
received FDA clearance for home use in July 2014 and, as a result of its
weight and thickness (only 10 g and 6 mm (0.24"), respectively), offers
patients a much more comfortable and less obtrusive monitoring solution in
comparison to conventional monitoring equipment.


For further questions:

LifeWatch AG
c/o Dynamics Group, Philippe Blangey / Doris Rudischhauser
Phone: +41 43 268 32 35
E-mail: investor-relations@lifewatch.com About LifeWatch AG:

LifeWatch AG, headquartered in Neuhausen am Rheinfall and listed on SIX
Swiss Exchange (LIFE),
Switzerland, is a leading healthcare technology and solution company,
specializing in advanced telehealth systems and wireless remote patient
monitoring services. LifeWatch's services provide physicians with critical
information to determine appropriate treatment and thereby improve patient
outcomes. LifeWatch AG has operative subsidiaries in the United States, in
Switzerland and in Israel, and is the parent company of LifeWatch Services
Inc., and LifeWatch Technologies, Ltd. LifeWatch Services, Inc. is a
leading U.S.-based provider of cardiac monitoring services and home sleep
testing of Obstructive Sleep Apnea (OSA). LifeWatch Technologies Ltd.,
based in Israel, is a leading developer and manufacturer of telemedicine
products. For additional information, please visit www.lifewatch.com.

Sign up for customized e-mail alerts and documentation requests at
http://www.irlifewatch.com/alert-service.aspx

About Vital Connect, Inc.:
Vital Connect is a Silicon Valley-based startup founded in 2011 with the
goal to develop the newest generation of technologies that help address
some of the most challenging healthcare issues in the world today. Vital
Connect's extensive expertise enables the company to create wireless,
wearable biosensors that are small, powerful, and capable of capturing
clinical-grade biometric measurements in a continuous, configurable and
non-obtrusive manner. Through various partnerships, Vital Connect solutions
will be available for use in hospitals, research facilities, doctor's
offices, care facilities and homes. For more information, visit:
www.vitalconnect.com.

This press release includes forward-looking statements. All statements
other than statements of historical facts contained in this press release,
including statements regarding future results of operations and financial
position, the business strategy, and plans and objectives for future
operations, are forward-looking statements. The words "believe," "may,"
"will," "estimate," "continue," "anticipate," "intend," "expect" and
similar expressions are intended to identify forward-looking statements.
LifeWatch AG has based these forward-looking statements largely on current
expectations and projections about future events and financial trends that
it believes may affect the financial condition, results of operations,
business strategy, short-term and long-term business operations and
objectives, and financial needs. These forward-looking statements are
subject to a number of risks, uncertainties and assumptions. In light of
these risks, uncertainties and assumptions, the forward-looking events and
circumstances described may not occur and actual results could differ
materially and adversely from those anticipated or implied in the
forward-looking statements. All forward-looking statements are based only
on data available to LifeWatch AG at the time of the issue of this press
release. LifeWatch AG does not undertake any obligation to update any
forward-looking statements contained in this press release as a result of
new information, future events or otherwise.

THIS PRESS RELEASE IS NOT BEING ISSUED IN THE UNITED STATES OF AMERICA AND
SHOULD NOT BE DISTRIBUTED TO UNITED STATES PERSONS OR PUBLICATIONS WITH A
GENERAL
CIRCULATION IN THE UNITED STATES. THIS PRESS RELEASE DOES NOT CONSTITUTE AN
OFFER OF SECURITIES OF LIFEWATCH AG OR ANY OF ITS SUBSIDIARIES FOR SALE IN
THE UNITED STATES, OR AN INVITATION TO SUBSCRIBE FOR OR PURCHASE ANY
SECURITIES OF LIFEWATCH AG OR ITS SUBSIDIARIES IN THE UNITED STATES. IN
ADDITION, THE SECURITIES OF LIFEWATCH AG AND ITS SUBSIDIARIES HAVE NOT BEEN
REGISTERED UNDER THE UNITED STATES
SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD OR DELIVERED WITHIN THE UNITED
STATES OR TO U.S. PERSONS ABSENT FROM REGISTRATION UNDER OR AN APPLICABLE
EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THE UNITED STATES
SECURITIES LAWS. ANY PUBLIC OFFERING OF SECURITIES TO BE MADE IN THE UNITED
STATES WILL BE MADE BY MEANS OF A PROSPECTUS THAT MAY BE OBTAINED FROM
LIFEWATCH AG OR ITS SUBSIDIARIES, AS APPLICABLE, AND WILL CONTAIN DETAILED
INFORMATION ABOUT THE ISSUER AND ITS MANAGEMENT AS WELL AS FINANCIAL
STATEMENTS OF THE ISSUER.



+++++
Additional features:
Document: http://n.equitystory.com/c/fncls.ssp?u=VRVBGUIXGE
Document title: LifeWatch AG signs agreement to utilize Vital Connect
Inc.'s HealthPatch(R) MD in its cardiac monitoring business


07.11.2014 News transmitted by EQS Schweiz AG.
The issuer is responsible for the contents of the release.

EQS publishes regulatory releases, media releases on the capital
market and press releases.
The EquityStory Group distributes authentic and real-time financial news
for over 1'300 listed companies.
The Swiss news archive can be found at www.equitystory.ch/news

---------------------------------------------------------------------------

Language:               English
Company:                LifeWatch AG
                        Rundbuckstrasse 6
                        8212 Neuhausen am Rheinfall
                        Switzerland
Phone:                  +41 52 632 00 50
Fax:                    +41 52 632 00 51
E-mail:
Internet:            www.lifewatch.com
ISIN:                   CH0012815459
Valor:                  811189
Listed:                 Freiverkehr in Berlin, Stuttgart; Frankfurt in Open
                        Market ; SIX

End of Announcement                             EQS Group News-Service

---------------------------------------------------------------------------

 



Weitere Meldungen: LifeWatch AG

Das könnte Sie auch interessieren: